The Potential Impact of Coronavirus (COVID-19) for Global Pharma and Biotech Con

Overview Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Healthcare systems are being put under significant pressure, at a time when many are already over-stretched, medical congresses are being cancelled and bans on non-essential travel and enforced home working are emerging. Meanwhile, at local country level, Italy has gone into a country-wide lockdown and in China measures to prevent the virus’ spread have seen API manufacturing plants go offline. This pharmaphorum webinar, held in association with IQVIA, will take place on Wednesday 18th March from 12:30-13:30 GMT with expert speakers outline potential scenarios, considerations and decisions that pharma and biotech would wish to plan for. Focus This COVID-19 continuity planning webinar will look at: •COVID-19's potential impact on global pharmaceutical market dynamics •Ways to support supply chain management •Maintaining open lines of communication with healthcare professionals •The application of artificial intelligence to potentially predict COVID-19 spread and patient infection •Learning from China